On the importance of a central beta-adrenoceptor site in the antiarrhythmic activity of beta-blockers.
D031841:Aconitum / Q000494:pharmacology; D000311:Adrenal Glands / Q000378:metabolism; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000526:Alprenolol / Q000494:pharmacology; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy*; D002395:Catecholamines / Q000378:metabolism; D003331:Coronary Vessels / Q000601:surgery; D004285:Dogs; D007031:Hypothalamus / Q000502:physiology*; D010433:Pentylenetetrazole / Q000494:pharmacology; D010852:Picrotoxin / Q000494:pharmacology; D010869:Pindolol / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011955:Receptors, Drug
D000319:Adrenergic beta-Antagonists; D000526:Alprenolol; D002395:Catecholamines; D010433:Pentylenetetrazole; D010852:Picrotoxin; D010869:Pindolol; D011433:Propranolol; D011955:Receptors, Drug